The median (IQR) TSPO values on days 8-10 among stroke patients in without versus with clinical worsening (0.26 (0.38) versus 0.45 (0.34), median test, p = 0.11), in mRS of <4 versus mRS of ≥4 (0.25 (0.24) versus 0.48 (0.46), p = 0.20), in BI of >30 versus BI of ≤30 (0.24 (0.23) versus 0.40 (0.45), p = 0.12), and survival versus death (0.33 (0.39) versus 0.50 (0.22), p = 0.13) individually. The gene discussed is TSPO; the disease is stroke disorder.